Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2529) 2529
Publication (414) 414
Paper (366) 366
Report (156) 156
Book / eBook (44) 44
Patent (42) 42
Conference Proceeding (17) 17
Book Chapter (12) 12
Book Review (12) 12
Data Set (6) 6
Streaming Audio (6) 6
Magazine Article (4) 4
Compact Disc (2) 2
Newspaper Article (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (598) 598
experiment (528) 528
cern lhc coll (503) 503
physics (488) 488
experimental results (477) 477
high energy physics (429) 429
male (414) 414
p p: scattering (411) 411
medicin och hälsovetenskap (403) 403
13000 gev-cms (400) 400
medical and health sciences (400) 400
physics of elementary particles and fields (398) 398
high energy physics - experiment (390) 390
p p: colliding beams (380) 380
natural sciences (371) 371
naturvetenskap (371) 371
female (368) 368
particle physics (366) 366
hep (336) 336
physics - high energy physics - experiment (330) 330
index medicus (315) 315
phenomenology (312) 312
physical sciences (302) 302
middle aged (297) 297
fysik (293) 293
hadron-hadron scattering (280) 280
adult (234) 234
ex (230) 230
aged (228) 228
subatomic physics (223) 223
subatomär fysik (223) 223
cms (208) 208
medicine (208) 208
medicin (179) 179
clinical medicine (170) 170
klinisk medicin (169) 169
physics, particles & fields (169) 169
nuclear experiment (166) 166
background (162) 162
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (149) 149
animals (149) 149
risk factors (128) 128
scattering [p p] (124) 124
colliding beams [p p] (111) 111
elementary particles, quantum field theory (105) 105
quantum field theories, string theory (105) 105
large hadron collider (102) 102
astrophysics (96) 96
analysis (95) 95
channel cross section: upper limit (93) 93
nuclear and particle physics. atomic energy. radioactivity (91) 91
research (91) 91
cardiac & cardiovascular systems (86) 86
mass dependence (86) 86
supersymmetry (83) 83
channel cross section: branching ratio: upper limit (82) 82
transverse momentum: missing-energy (82) 82
astronomy & astrophysics (81) 81
adolescent (80) 80
astronomy, astrophysics and cosmology (79) 79
sweden (79) 79
物理学 (79) 79
bottom: particle identification (74) 74
cern lab (73) 73
risk (72) 72
treatment outcome (71) 71
final state:jet lepton (70) 70
quarks (70) 70
luminosity (69) 69
particle collisions (68) 68
cholesterol (66) 66
time factors (66) 66
transverse momentum (66) 66
beyond standard model (65) 65
jet: bottom (65) 65
z0: leptonic decay (64) 64
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (62) 62
parton distributions (62) 62
aged, 80 and over (61) 61
muon: pair production (61) 61
endocrinology & metabolism (60) 60
higgs particle: hadroproduction (59) 59
nuclear energy (59) 59
nuclear physics, heavy ions, hadrons (59) 59
measurement science and instrumentation (58) 58
top: pair production (57) 57
cholesterol, ldl - blood (56) 56
kinematics (56) 56
physics, nuclear (56) 56
oncology (55) 55
genetic aspects (54) 54
hep-ex (54) 54
data analysis method (53) 53
health aspects (52) 52
mass spectrum: (52) 52
neurosciences (52) 52
particle physics - experiment (52) 52
high energy astrophysical phenomena (51) 51
rats (51) 51
science & technology (51) 51
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (16) 16
UTL at Downsview - May be requested (15) 15
Gerstein Science - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Online Resources - Online (3) 3
UofT at Mississauga - Stacks (3) 3
Music - Circulation Desk (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2716) 2716
Swedish (83) 83
Norwegian (19) 19
French (8) 8
Danish (7) 7
German (7) 7
Chinese (3) 3
Latin (3) 3
Italian (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Atherosclerosis
: biology and clinical science
by Olsson, Anders G and European Atherosclerosis Society
1987, ISBN 9780443031694, xvii, 506
Arteriosclerosis | Atherosclerosis
Book
Details down arrow
2. Studies on serum lipoproteins and lipid metabolism
: analysis of a random sample of 40 year old men
by Walldius, Göran and Rössner, Stephan and Olsson, Anders G
1980, Volume no. 637, 47
Book
Details down arrow
3. PCSK9-hämmare kan minska total dödlighet - Resultat och konsekvenser av ODYSSEY-studien
by Olsson, Anders G and Olsson, Anders
Lakartidningen, ISSN 0023-7205, 01/2019, Volume 116, Issue 5, pp. 1 - 3
Journal Article
Details down arrow
4. Full Text Early, intensive atorvastatin treatment reduces first and recurrent hard cardiovascular events after acute coronary syndrome
by Szarek, Michael and DeMicco, David and Olsson, Anders G and Schwartz, Gregory G and Fayyad, Rana
Circulation, ISSN 0009-7322, 11/2016, Volume 134, Issue 19
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
by Schwartz, Gregory G and Olsson, Anders G and Abt, Markus and Ballantyne, Christie M and Barter, Philip J and Brumm, Jochen and Chaitman, Bernard R and Holme, Ingar M and Kallend, David and Leiter, Lawrence A and Leitersdorf, Eran and McMurray, John J.V and Mundl, Hardi and Nicholls, Stephen J and Shah, Prediman K and Tardif, Jean-Claude and Wright, R. Scott and dal-OUTCOMES Investigators and Linköpings universitet and Institutionen för medicin och hälsa and Hjärt- och Medicincentrum and Östergötlands Läns Landsting and Hälsouniversitetet and Endokrin- och magtarmmedicinska kliniken US and Internmedicin
The New England Journal of Medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 22, pp. 2089 - 2099
Dalcetrapib, an inhibitor of cholesteryl ester transfer protein, raises HDL cholesterol levels. In this clinical trial involving patients with an acute... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | STATIN THERAPY | CARDIOVASCULAR EVENTS | HIGH-RISK | HDL CHOLESTEROL | RANDOMIZED CONTROLLED-TRIAL | IT-TIMI 22 | TYPE-2 DIABETES-MELLITUS | HIGH-DENSITY-LIPOPROTEIN | ARTERY-DISEASE | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Biomarkers - blood | Apolipoproteins - blood | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Sulfhydryl Compounds - adverse effects | Anticholesteremic Agents - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - mortality | Cholesterol, HDL - blood | Cholesterol, LDL - blood | Female | Aged | Blood Pressure - drug effects | Sulfhydryl Compounds - therapeutic use | C-Reactive Protein - analysis | Measurement | Cholesterol, HDL | Patient outcomes | Dosage and administration | Research | Acute coronary syndrome | Drug therapy | Health aspects | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | C-reactive protein | Heart attacks | Mortality | Cardiovascular disease | Angina | Coronary artery disease | Cholesterol | Cholesteryl ester transfer protein | Studies | Ischemia | Diet | Biomarkers | Blood pressure | Acute coronary syndromes | Cardiovascular diseases | Heart diseases | Lipoproteins (high density) | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Abstract 11806: Early, Intensive Atorvastatin Treatment Reduces First and Recurrent Hard Cardiovascular Events After Acute Coronary Syndrome
by Schwartz, Gregory G and Fayyad, Rana and DeMicco, David and Szarek, Michael and Olsson, Anders G
Circulation, ISSN 0009-7322, 11/2016, Volume 134, Issue Suppl_1 Suppl 1, pp. A11806 - A11806
BackgroundEarly, intensive statin treatment is standard of care after acute coronary syndrome (ACS), but only one placebo (PBO)-controlled trial has... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
by Raal, Frederick J, Prof and Stein, Evan A, Prof and Dufour, Robert, MD and Turner, Traci, MD and Civeira, Fernando, MD and Burgess, Lesley, Prof and Langslet, Gisle, MD and Scott, Russell, Prof and Olsson, Anders G, Prof and Sullivan, David, MD and Hovingh, G Kees, MD and Cariou, Bertrand, MD and Gouni-Berthold, Ioanna, MD and Somaratne, Ransi, MD and Bridges, Ian, MSc and Scott, Rob, MD and Wasserman, Scott M, MD and Gaudet, Daniel, Prof and RUTHERFORD-2 Investigators and Avdelningen för kardiovaskulär medicin and Endokrinmedicinska kliniken and Linköpings universitet and Institutionen för medicin och hälsa and Hjärt- och Medicincentrum and Östergötlands Läns Landsting and Hälsouniversitetet
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9965, pp. 331 - 340
Summary Background Heterozygous familial hypercholesterolaemia is characterised by low cellular uptake of LDL cholesterol, increased plasma LDL cholesterol... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | DENSITY-LIPOPROTEIN CHOLESTEROL | EFFICACY | REDUCTION | LDL-C | DISEASE | SUBTILISIN/KEXIN TYPE 9 | MONOCLONAL-ANTIBODY | RECEPTOR GENE | UPDATE | GUIDANCE | Proprotein Convertases - antagonists & inhibitors | Double-Blind Method | Drug Administration Schedule | Hyperlipoproteinemia Type II - blood | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Cholesterol, LDL - drug effects | Male | Treatment Outcome | Anticholesteremic Agents - adverse effects | Young Adult | Antibodies, Monoclonal - administration & dosage | Anticholesteremic Agents - administration & dosage | Injections, Subcutaneous | Adolescent | Cholesterol, LDL - metabolism | Adult | Female | Heterozygote | Hyperlipoproteinemia Type II - drug therapy | Serine Endopeptidases | Hyperlipoproteinemia Type II - genetics | Proprotein Convertase 9 | Hypercholesterolemia | Low density lipoproteins | Atherosclerosis | Clinical trials | Carbohydrate metabolism | Genetic aspects | Trans fatty acids | Statins | Mortality | Cardiovascular disease | Lipids | Mutation | Low density lipoprotein | Drug dosages | Cholesterol | Life Sciences | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text The authors reply
by Schwartz, Gregory G and Olsson, Anders G and Barter, Philip J
New England Journal of Medicine, ISSN 0028-4793, 02/2013, Volume 368, Issue 9, pp. 869 - 870
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients: The GAUSS Randomized Trial
by Sullivan, David and Olsson, Anders G and Scott, Rob and Kim, Jae B and Xue, Allen and Gebski, Val and Wasserman, Scott M and Stein, Evan A and Linköpings universitet and Institutionen för medicin och hälsa and Hjärt- och Medicincentrum and Östergötlands Läns Landsting and Hälsouniversitetet and Endokrin- och magtarmmedicinska kliniken US and Internmedicin
JAMA, ISSN 0098-7484, 12/2012, Volume 308, Issue 23, pp. 2497 - 2506
CONTEXT An estimated 10% to 20% of patients cannot tolerate statins or adequate doses to achieve treatment goals. Plasma proprotein convertase subtilisin/kexin... 
MEDICINE, GENERAL & INTERNAL | THERAPY | EFFICACY | SAFETY | LDL | HIGH-RISK | PRIMARY HYPERCHOLESTEROLEMIA | EZETIMIBE | Proprotein Convertases - antagonists & inhibitors | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Coronary Disease - epidemiology | Male | Risk | Hypercholesterolemia - drug therapy | Contraindications | Musculoskeletal Pain - chemically induced | Dose-Response Relationship, Drug | Injections, Subcutaneous | Serine Endopeptidases - immunology | Cholesterol, LDL - blood | Female | Muscular Diseases - chemically induced | Syncope - chemically induced | Hip Fractures - chemically induced | Hypercholesterolemia - blood | Coronary Disease - chemically induced | Double-Blind Method | Cholesterol, LDL - drug effects | Anticholesteremic Agents - adverse effects | Proprotein Convertases - immunology | Coronary Disease - prevention & control | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Antibodies, Monoclonal - administration & dosage | Anticholesteremic Agents - administration & dosage | Aged | Proprotein Convertase 9 | Clinical trials | Monoclonal antibodies | Low density lipoprotein | Patients | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. PCSK9-hämning – En ny era i kolesterolbehandlingen
by Olsson, Anders G
Lakartidningen, ISSN 0023-7205, 2015, Volume 112, Issue 8, p. 340
Journal Article
Details down arrow
11. Full Text Fasting Triglycerides Predict Recurrent Ischemic Events in Patients With Acute Coronary Syndrome Treated With Statins
by Schwartz, Gregory G., MD, PhD and Abt, Markus, PhD and Bao, Weihang, PhD and DeMicco, David, PharmD and Kallend, David, MD and Miller, Michael, MD and Mundl, Hardi, MD and Olsson, Anders G., MD, PhD and Region Östergötland and Medicinska fakulteten and Avdelningen för kardiovaskulär medicin and Endokrinmedicinska kliniken and Linköpings universitet and Hjärt- och Medicincentrum and Institutionen för medicin och hälsa
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 21, pp. 2267 - 2275
Abstract Background Most patients with acute coronary syndrome (ACS) are treated with statins, which reduce atherogenic triglyceride-rich lipoproteins. It is... 
Cardiovascular | Internal Medicine | lipids | myocardial infarction | unstable angina | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVASCULAR EVENTS | DENSITY-LIPOPROTEIN-CHOLESTEROL | OF-FUNCTION MUTATIONS | VASCULAR-DISEASE | TRIAL | WOMEN | HEART-DISEASE | RISK-FACTOR | NONFASTING TRIGLYCERIDES | ACUTE MYOCARDIAL-INFARCTION | Predictive Value of Tests | Recurrence | Fasting | Risk Assessment | Humans | Middle Aged | Male | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cholesterol, HDL - blood | Cholesterol, LDL - blood | Female | Aged | Medical research | Relapse | Hospitals, Military | Triglycerides | Coronary heart disease | Diseases | Cardiovascular agents | Sects | Ischemia | Cardiac patients | Medicine, Experimental | Blood lipids | Statins | Low density lipoproteins | Analysis | Cardiology | Cardiovascular disease | Heart attacks | Acute coronary syndromes | Angina pectoris | Cholesterol | Clinical Medicine | lipids; myocardial infarction; unstable angina | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Riktlinjer för kolesterolbehandling--stoppklossen kvar i Stockholm
by Olsson, Anders G
Lakartidningen, ISSN 0023-7205, 2014, Volume 111, Issue 20, p. 885
Journal Article
Details down arrow
13. Guidelines for cholesterol treatment--the obstacle remains in Stockholm
by Olsson, Anders G
Lakartidningen, ISSN 0023-7205, 05/2014, Volume 111, Issue 20, p. 885
Sweden | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cholesterol, LDL - blood | Practice Guidelines as Topic
Journal Article
Details down arrow
14. Full Text RE: Praluent (Alirocumab)-Induced Renal Injury
by Rosenson, Robert S and Larrey, Dominique and Waters, David D and Olsson, Anders G and Members of the Phase 3 Data Monitoring Committee for PRALUENT
Journal of Pharmacy Practice, ISSN 0897-1900, 4/2018, Volume 31, Issue 2, pp. 138 - 139
acute renal injury | alirocumab | rosuvastatin | Letter to the Editor
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
by Willeit, Peter and Ridker, Paul M and Nestel, Paul J and Simes, John and Tonkin, Andrew M and Pedersen, Terje R and Schwartz, Gregory G and Olsson, Anders G and Colhoun, Helen M and Kronenberg, Florian and Drechsler, Christiane and Wanner, Christoph and Mora, Samia and Lesogor, Anastasia and Tsimikas, Sotirios and Avdelningen för kardiovaskulär medicin and Medicinska fakulteten and Region Östergötland and Endokrinmedicinska kliniken and Linköpings universitet and Institutionen för medicin och hälsa and Hjärt- och Medicincentrum
The Lancet, ISSN 0140-6736, 10/2018, Volume 392, Issue 10155, pp. 1311 - 1320
Background: Elevated lipoprotein(a) is a genetic risk factor for cardiovascular disease in general population studies. However, its contribution to risk for... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | SERIES-LIPOPROTEIN | MYOCARDIAL-INFARCTION | TARGETING APOLIPOPROTEIN(A) | AORTIC-STENOSIS | DOUBLE-BLIND | ACUTE CORONARY SYNDROMES | OXIDIZED PHOSPHOLIPIDS | TYPE-2 DIABETES-MELLITUS | PRIMARY PREVENTION | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Male | Biomarkers - blood | Hypercholesterolemia - drug therapy | Randomized Controlled Trials as Topic | Lipoprotein(a) - drug effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Cholesterol, HDL - blood | Cholesterol, LDL - blood | Female | Aged | Lipoprotein(a) - blood | Medical research | Care and treatment | Patient outcomes | Low density lipoproteins | Coronary heart disease | Lipoprotein A | Risk factors | Cardiovascular agents | Blood cholesterol | Analysis | Cardiac patients | Medicine, Experimental | Statins | Lipoproteins (low density) | Therapy | Clinical trials | Cardiovascular disease | Population studies | Blood pressure | Heart diseases | Lipoproteins (high density) | Data analysis | Stroke | Medical treatment | Diabetes mellitus | Health risks | Data processing | Risk analysis | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Studies | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Smoking | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights